|
Volumn 17, Issue SUPPL. 4, 2002, Pages 377-384
|
Current use of atypical antipsychotics
|
Author keywords
Amisulpride; Atypical antipsychotic drugs; Negative symptoms; Positive symptoms; Schizophrenia
|
Indexed keywords
AMISULPRIDE;
ARIPIPRAZOLE;
CHLORPROMAZINE;
CLOZAPINE;
DOPAMINE 2 RECEPTOR;
DOPAMINE 3 RECEPTOR;
FLUPENTIXOL;
FLUPHENAZINE;
HALOPERIDOL;
NEUROLEPTIC AGENT;
OLANZAPINE;
QUETIAPINE;
RESERPINE;
RISPERIDONE;
THIORIDAZINE;
ZIPRASIDONE;
ZOTEPINE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOPAMINERGIC SYSTEM;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG TOLERABILITY;
EXTRAPYRAMIDAL SYMPTOM;
HEMATOLOGIC DISEASE;
HUMAN;
HYPERSALIVATION;
MULTICENTER STUDY;
ORTHOSTATIC HYPOTENSION;
PHENOMENOLOGY;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
SCHIZOPHRENIA;
SEDATION;
SIDE EFFECT;
TREATMENT OUTCOME;
WEIGHT GAIN;
XEROSTOMIA;
|
EID: 0036689436
PISSN: 09249338
EISSN: None
Source Type: Journal
DOI: 10.1016/S0924-9338(03)00077-4 Document Type: Review |
Times cited : (13)
|
References (21)
|